Analysis of in vitro and in vivo sensitivity of oral cancer cells to methotrexate

Experimental Oncology

Volumn 31, Issue 2, 2009, Pages 118-120

  Pai, R B ^a   Lalitha, R M ^a,b   Pai, S B ^a   Kumaraswamy, S V ^a,c   Lalitha, N ^a   Bhargava, M K ^a  

^a KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

^b M S RAMAIAH UNIVERSITY OF APPLIED SCIENCES   (India)

^c V S Dental College and Hospital   (India)

Author keywords

Drug sensitivity resistance; Intrinsic; Methotrexate; Oral cancer

Indexed keywords

METHOTREXATE; ANTINEOPLASTIC ANTIMETABOLITE;

ADULT; AGED; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG RESPONSE; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUTH CANCER; PILOT STUDY; CANCER STAGING; CELL SURVIVAL; CLINICAL TRIAL; DRUG EFFECT; DRUG RESISTANCE; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; TREATMENT OUTCOME;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 68849098424     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Nair U, Bartsch H, Nair J. Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis 2004; 19: 251-262 (Pubitemid 39028948)
2. Sanghvi LD, Rao DN, Joshi S. Epidemiology of head and neck cancers. Semin Surg Oncol 1989; 5: 305-309
3. Pai SB, Pai RB, Lalitha RM, et al. Expression of oncofoetal marker carcinoembryonic antigen in oral cancers in South India - a pilot study. Int J Oral Maxillofac Surg 2006; 35: 746-749
4. Guardiola E, Peyrade F, Chaigneau L, et al. Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer. Eur J Cancer 2004; 40: 2071-2076 (Pubitemid 39165540)
5. Katori H, Tsukuda M, Taguchi T. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol 2007; 59: 789-794 (Pubitemid 46440602)
6. Specenier PM, Vermorken JB. Current concepts for the management of head and neck cancer: Chemotherapy. Oral Oncol 2008; 45: 409-415
7. Bastow KF, Prabhu R, Cheng YC. The intracellular content of dihydrofolate reductase: possibilities for control and implications for chemotherapy. Adv Enzyme Regul 1984; 22: 15-26.
8. Bouchard J, Bastow KF, Starnes MC, et al. Characterization of dihydrofolate reductase-related DNA and RNA from human KB cell subclones containing different amounts of enzyme. Cancer Res 1985; 45: 1717-1722 (Pubitemid 15079129)
9. van der Laan BF, Jansen G, Kathmann I, et al. Mechanisms of acquired resistance to methotrexate in a human squamous carcinoma cell line of the head and neck, exposed to different treatment schedules. Eur J Cancer 1991; 27: 1274-1278
10. Zhao R, Goldman ID. Resistance to antifolates. Oncogene 2003; 22: 7431-7457
11. Domin BA, Grill SP, Cheng Y. Establishment of dihydrofolate reductase-increased human cell lines and relationship between dihydrofolate reductase levels and gene copy. Cancer Res 1983; 43: 2155-2158
12. Blumenthal RD. An overview of chemosensitivity testing. Methods Mol Med 2005; 110: 3-18.
13. Blumenthal RD, Goldenberg DM. Methods and goals for the use of in vitro and in vivo chemosensitivity testing. Mol Biotechnol 2007; 35: 185-197
14. Pathak KA, Juvekar AS, Radhakrishnan DK, et al. In vitro chemosensitivity profile of oral squamous cell cancer and its correlation with clinical response to chemotherapy. Indian J Cancer 2007; 44: 142-146